CFP
HOME HELP CONTACT US FEEDBACK SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES SEARCH
 QUICK SEARCH:   [advanced]


     


Can Fam Physician
Vol. 53, No. 8, August 2007, p.1300
Copyright © 2007 by The College of Family Physicians of Canada
This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubnov-Raz, G.
Right arrow Articles by Koren, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dubnov-Raz, G.
Right arrow Articles by Koren, G.

Letters

Response

Gal Dubnov-Raz, MD MSc, Yaron Finkelstein, MD and Gideon Koren, MD FRCPC
Toronto, Ont by e-mail

We thank Dr Schwalfenberg for his interest in Motherisk Update. Our recent review regarding {omega}-3 fatty acids during pregnancy1 begins with a clinical question, as is customary with Motherisk Updates. The question was about whether {omega}-3 supplementation should be recommended to pregnant women and not whether it affects the human brain, photoreceptors, and cell functions in general. Therefore, the focus of the review was to look at the available interventional trials of {omega}-3 supplementation during pregnancy, which sometimes contradict what was previously believed based on observational studies.

Our review delineates the possible areas of benefit, but concludes, "Until evidence accumulates, no recommendation should be made to encourage pregnant women to take {omega}-3 fatty acid supplements." A similar conclusion was drawn in another recent, similar paper.2 A meta-analysis of the highest-quality randomized control trials on {omega}-3 supplementation during pregnancy (published after the submission of our review and hence not included) concluded that {omega}-3 supplementation did not influence the rates of preterm deliveries, preeclampsia, eclampsia, or infants with low birth weights.3 There was also no influence on birth weight. Adding these findings to our discussion strengthens our conclusion that there is no clear benefit of {omega}-3 fatty acid supplementation to maternal or infant health.

To the specific points raised by Dr Schwalfenberg: reference 10 is used in the article for both observational and interventional trials because it is a review article describing both. The second point concerns the prevalence of preeclampsia in the paper by Smuts et al4; it is a matter of basic statistical analysis. The "50% risk reduction" in prevalence between groups is not statistically significant, with {chi}2 analysis yielding P=.3. Finally, the relevant sources of funding to the authors and the Motherisk program and potential conflicts of interest were fully disclosed in the article. These are routinely found at the end of the article in the Motherisk box.


    References
 TOP
 References
 

  1. Dubnov-Raz G, Finkelstein Y, Koren G. {omega}-3 fatty acid supplementation during pregnancy. For mother, baby, or neither? Can Fam Physician 2007;53:817-8.[Abstract/Free Full Text]
  2. Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 2007;76:189-203.[Medline]
  3. Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83:1337-44.[Abstract/Free Full Text]
  4. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubnov-Raz, G.
Right arrow Articles by Koren, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dubnov-Raz, G.
Right arrow Articles by Koren, G.


HOME HELP CONTACT US FEEDBACK SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES SEARCH